Epidermal growth factor receptor targeting in cancer: a review of trends and strategies

C Yewale, D Baradia, I Vhora, S Patil, A Misra - Biomaterials, 2013 - Elsevier
The epidermal growth factor receptor (EGFR) is a cell-surface receptor belonging to ErbB
family of tyrosine kinase and it plays a vital role in the regulation of cell proliferation, survival …

EGFR signaling in breast cancer: bad to the bone

J Foley, NK Nickerson, S Nam, KT Allen… - Seminars in cell & …, 2010 - Elsevier
The epidermal growth factor receptor (EGFR) is a member of the ErbB family of receptor
tyrosine kinases. This family includes EGFR/ErbB1/HER1, ErbB2/HER2/Neu ErbB3/HER3 …

Comparison of ER, PR and HER-2/neu (C-erb B 2) reactivity pattern with histologic grade, tumor size and lymph node status in breast cancer

BY Azizun-Nisa, F Raza, N Kayani - Asian Pac J Cancer Prev, 2008 - journal.waocp.org
Introduction: Carcinoma of the breast is the most common malignancy of women in Karachi.
The currentstudy was conducted with the objective of assessing estrogen receptor (ER) …

HB-EGF is a potent inducer of tumor growth and angiogenesis

PP Ongusaha, JC Kwak, AJ Zwible, S Macip… - Cancer research, 2004 - AACR
Heparin-binding epidermal growth factor-like growth factor (HB-EGF) has been shown to
stimulate the growth of a variety of cells in an autocrine or paracrine manner. Although HB …

[HTML][HTML] ErbB/HER ligands in human breast cancer, and relationships with their receptors, the bio-pathological features and prognosis

F Revillion, V Lhotellier, L Hornez, J Bonneterre… - Annals of oncology, 2008 - Elsevier
Background The aim of this study is to provide an expression profile of ErbB/HER ligands in
breast cancer. We analysed the relationships with their receptors, the bio-pathological …

TRIM11 is overexpressed in high-grade gliomas and promotes proliferation, invasion, migration and glial tumor growth

K Di, ME Linskey, DA Bota - Oncogene, 2013 - nature.com
TRIM11 (tripartite motif-containing protein 11), an E3 ubiquitin ligase, is known to be
involved in the development of the central nervous system. However, very little is known …

Breast cancer biomarkers and molecular medicine

JS Ross, GP Linette, J Stec, E Clark… - Expert review of …, 2003 - Taylor & Francis
The first part of this two-part review of established and emerging breast cancer biomarkers
and molecular diagnostics considers breast cancer predisposition, screening tests for …

Monocytes/macrophages support mammary tumor invasivity by co-secreting lineage-specific EGFR ligands and a STAT3 activator

P Vlaicu, P Mertins, T Mayr, P Widschwendter… - BMC cancer, 2013 - Springer
Background Tumor-associated macrophages (TAM) promote malignant progression, yet the
repertoire of oncogenic factors secreted by TAM has not been clearly defined. We sought to …

The Role of Membrane-Type 1 Matrix Metalloproteinase–Substrate Interactions in Pathogenesis

H Lee, L Ibrahimi, DT Azar, KY Han - International Journal of Molecular …, 2023 - mdpi.com
A protease is an enzyme with a proteolytic activity that facilitates the digestion of its
substrates. Membrane-type I matrix metalloproteinase (MT1-MMP), a member of the broader …

Heregulin/ErbB3 signaling enhances CXCR4-driven Rac1 activation and breast cancer cell motility via hypoxia-inducible factor 1α

C Lopez-Haber, L Barrio-Real… - … and cellular biology, 2016 - Taylor & Francis
The growth factor heregulin (HRG), a ligand of ErbB3 and ErbB4 receptors, contributes to
breast cancer development and the promotion of metastatic disease, and its expression in …